Vycor Medical (VYCO) EBITDA Margin (2010 - 2026)
Vycor Medical (VYCO) reported EBITDA Margin of 4.39% for Q1 2026, up 1322.0% year-over-year from 0.31% in Q1 2025, and up 129.16% quarter-over-quarter from 15.04% in Q4 2025.
Vycor Medical (VYCO) EBITDA Margin (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of EBITDA Margin data on file, last reported at 4.39% in Q1 2026.
- EBITDA Margin for Q1 2026 came in at 4.39%, up 1322.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.73% (up 609.0% YoY), and the FY2025 annual result was 3.89%, up 286.0% from the prior year.
- EBITDA Margin improved to 4.39% in Q1 2026 per VYCO's latest filing, from 15.04% in the prior quarter.
- Over five years, EBITDA Margin peaked at 14.17% in Q2 2023 and troughed at 42.96% in Q4 2022.
- A 5-year average of 12.17% and a median of 9.08% in 2024 frame the typical range for EBITDA Margin.
- On a YoY basis, EBITDA Margin climbed as much as 5838 bps in 2022 and fell as far as 3815 bps in 2022.
- A 5-year view of EBITDA Margin shows it stood at 42.96% in 2022, then gained by 30 bps to 30.19% in 2023, then surged by 95 bps to 1.48% in 2024, then plunged by 916 bps to 15.04% in 2025, then jumped by 129 bps to 4.39% in 2026.
- Business Quant data shows VYCO's EBITDA Margin at 4.39% in Q1 2026, 15.04% in Q4 2025, and 0.96% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.94% |
| 10 | Vycor Medical | - | - | 375,153.00 | 4.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.39% |
| Dec 31, 2025 | -15.04% |
| Sep 30, 2025 | 0.96% |
| Jun 30, 2025 | 4.81% |
| Mar 31, 2025 | -8.84% |
| Dec 31, 2024 | -1.48% |
| Sep 30, 2024 | -15.30% |
| Jun 30, 2024 | -2.47% |
| Mar 31, 2024 | -9.08% |
| Dec 31, 2023 | -30.19% |
| Sep 30, 2023 | -16.82% |
| Jun 30, 2023 | 14.17% |
| Mar 31, 2023 | 1.90% |
| Dec 31, 2022 | -42.96% |
| Sep 30, 2022 | -37.04% |
| Jun 30, 2022 | -30.19% |
| Mar 31, 2022 | -23.75% |
| Dec 31, 2021 | -68.34% |
| Sep 30, 2021 | 1.11% |
| Jun 30, 2021 | -1.91% |